MedPath

Bioinductive Patch for Full-Thickness Rotator Cuff Tears

Phase 4
Recruiting
Conditions
Rotator Cuff Tears
Rotator Cuff Tear Arthropathy
Interventions
Procedure: arthroscopic rotator cuff repair
Diagnostic Test: Ultrasound Imaging
Biological: Bioinductive implant
Registration Number
NCT05439850
Lead Sponsor
Henry Ford Health System
Brief Summary

The purpose of this randomized-controlled study is to compare outcomes of arthroscopic rotator cuff repair augmented with a Bioinductive Implant (study group) to standard arthroscopic rotator cuff repair (control group). The primary outcome of this study is rotator cuff repair integrity (absence of full- or partial-thickness defect) demonstrated on ultrasound at 1-year postoperatively. The investigators hypothesize that the study group will have higher rates of repair integrity demonstrated on ultrasound at 1-year postoperatively.

Detailed Description

A bioinductive patch is an implant that may foster tendon regrowth and healing following surgery. Patients will be randomized into one of two groups: control and investigational. All surgical patients will have failed non-surgical/conservative options for 6 weeks. Patients in the "control group" will receive the standard surgery (arthroscopic rotator cuff repair) . Patients in the "experimental group" will receive the same surgical treatment, with the addition of the bioinductive patch. This patch will be implanted during surgery. Then, using a combination of ultrasound studies and other measures, the investigators will assess how well the patch works compared to surgery alone.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
78
Inclusion Criteria
  • Indicated and scheduled for arthroscopic rotator cuff repair.
  • Full-thickness medium (1-3 cm), large (3-5 cm), and massive (>5 cm) rotator cuff tears involving the supraspinatus and/or infraspinatus tendons demonstrated on magnetic resonance or ultrasound imaging.
  • Chronic, degenerative rotator cuff tears.
  • Ability to read and understand English.
  • Age ≥18 years
  • Patient failed ≥6 weeks of conservative treatment, which included structured, in-person physical therapy or documented home therapy
Exclusion Criteria
  • Patient scheduled for open or mini-open rotator cuff repair
  • Prior surgery of affected shoulder (except diagnostic arthroscopy)
  • Partial-thickness rotator cuff tears
  • Small (<1 cm) rotator cuff tears
  • Rotator cuff tears involving the subscapularis tendon
  • Acute and traumatic rotator cuff tears
  • Active infection
  • Cancer
  • Autoimmune and rheumatologic disorders, including rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosus

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Study Grouparthroscopic rotator cuff repairIdentical surgical treatment as control group plus bio-inductive patch implant. Ultrasound postoperatively at 1 year.
Control GroupUltrasound ImagingSurgical treatment alone, consisting of arthroscopic rotator cuff repair. Ultrasound postoperatively at 1 year.
Study GroupUltrasound ImagingIdentical surgical treatment as control group plus bio-inductive patch implant. Ultrasound postoperatively at 1 year.
Control Grouparthroscopic rotator cuff repairSurgical treatment alone, consisting of arthroscopic rotator cuff repair. Ultrasound postoperatively at 1 year.
Study GroupBioinductive implantIdentical surgical treatment as control group plus bio-inductive patch implant. Ultrasound postoperatively at 1 year.
Primary Outcome Measures
NameTimeMethod
Rotator cuff repair integrityPreoperative to 1 year postoperative

absence of full- or partial-thickness defect as demonstrated on ultrasound at 1-year postoperatively.

Secondary Outcome Measures
NameTimeMethod
Reoperation2 years postoperative

Whether or not patients required another operation.

PROMs scores for upper extremity functionPreoperative to 2 years postoperative

Patient-Reported Outcome Measures (PROMs) scores for upper extremity function. A T-score is given with a standard deviation based on the patients answers to the computerized adaptive test. The metrics have been designed to conform to a 0 - 100-point scale, with a score of 50 representing the mean of the population at large, 0 representing the minimum, and 100 representing the maximum function.

PROMs scores for upper extremity pain interferencePreoperative to 2 years postoperative

Patient-Reported Outcome Measures (PROMs) scores for upper extremity pain and how it interferes with the patients daily life. A T-score is given with a standard deviation based on the patients answers to the computerized adaptive test. The metrics have been designed to conform to a 10 - 90-point scale, with a score of 50 representing the mean of the population at large, 10 representing the minimum, and 90 representing the maximum function. A higher T-score represents higher pain interference (worse).

Shoulder Range of MotionPreoperative to 2 years postoperative

Standard range of motion values collected by the surgeon during preoperative and followup visits

PROMs scores for depressionPreoperative to 2 years postoperative

Patient-Reported Outcome Measures (PROMs) scores for depression. A T-score is given with a standard deviation based on the patients answers to the computerized adaptive test. The metrics have been designed to conform to a 10 - 90-point scale, with a score of 50 representing the mean of the population at large, 10 representing the minimum, and 90 representing the maximum function. A higher T-score represents higher increased depression (worse).

Shoulder StrengthPreoperative to 2 years postoperative

Standard shoulder strength values collected by the surgeon during preoperative and followup visits. Medical Research Council Manual Muscle Testing scale will be used to measure the patient's strength on a 0 to 5 scale with 0 being the minimum and 5 being the maximum. Higher scores are better/normal.

ComplicationsIntraoperative to 2 years postoperative

Both intra- and postoperative complications will be collected.

Trial Locations

Locations (1)

Henry Ford Health

🇺🇸

Detroit, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath